The mechanism ofIL-17 in human T1DM provides a new view on the pathogenesis of the disease with periodontitis and implies a novel potential therapeutic strategy in T1DM by controlling therole of IL-17. The gene discussed is IL17A; the disease is type 1 diabetes mellitus.